U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541404) titled 'MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma' on April 06.
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the NeoCast Embolic System for treatment of symptomatic subacute or chronic subdural hematoma (SDH) adjunctive to surgery.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Subdural Hematoma
Intervention:
DEVICE: NeoCast Embolic System
NeoCast will be used to embolize a participant's middle meningeal artery in an endovascular procedure before or after adjunctive surgery to drain the hem...